Pretty stock standard auditor comments for ASX listed stocks this end of town. Same comments on reports year on year for majority of ASX stocks that are not yet generating revenues. For all the doomsday artists especially the 3 know it all Stooges we have on these forums, one of which didn't even realise the company was tail end of multiple Phase 2 HUMAN trials... BIT will have no problem raising cash if required, the issue is under which circumstances....
The more important piece of info is...
" Biotron is now finalising the plans for a Phase 2 placebo-controlled, proof-of-concept, dosing-finding study for
COVID-19, using FDA-agreed end points.
As with all of its programs, the Company’s focus is on generating high-value data to de-risk the portfolio ahead
of licensing to a major pharmaceutical company for late-stage development, marketing and sales."
The company just reiterated that Phase 2 COVID trials are going ahead as planned with very thorough and meticulous planning to ensure appropriate data to satisfy FDA and potential partners.
Ann: Full Year Statutory Accounts and Appendix 4E, page-7
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $49.62M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $13.80K | 247.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 37000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.7¢ |
Change
-0.002 ( 5.56 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.4¢ | 173626 | ||
| Last updated 15.02pm 05/06/2024 ? | |||||
| BIT (ASX) Chart |